You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
BACK TO ALL NEWS/

05-07-2017

Launch of new 350 Million Bond and tender offer indicative results

Kedrion SpA successfully completed the repurchase by means of a cash tender offer for part of the outstanding notes of its senior, unsecured and unrated bond of Euro 300 million 4.625%, due in April 2019. The repurchase will be finalized in the next few days. At the expiration deadline of the tender offer, €91,080,000 in aggregate principal amount of the notes had been validly tendered pursuant to the offer.

In addition, Kedrion announces the upcoming issuance of a new bond of Euro 350 million 3.000%, due on 12 July 2022 issued below par at 99.43%.

Such bond shall be placed with leading international institutional investors and will be listed on the Irish Stock Exchange by the date of issuance, scheduled on 12 July 2017.
 
The transaction, officially announced at the end of a three-day European road show through London, Paris and Milan, was received remarkably well by the international financial community.

The proceeds from the issuance of such bonds will be mainly used to repay existing indebtedness of the group, to pay repurchase costs in connection with the tender offer of the notes due 2019 and, for the remaining portion, for general corporate purposes, including the funding of capital expenditures.

In relation to the issuance of the new bond, Banca IMI SpA, Mediobanca – Banca di Credito Finanziario S.p.A. and Natixis acted as Joint Lead Managers and UBI Banca S.p.A. as Co-Manager.

For more information please contact: investor@kedrion.com